Evidence map›Paper›PMID 23233547›Full record

ArticleGenome research2013

TRIM28 repression of retrotransposon-based enhancers is necessary to preserve transcriptional dynamics in embryonic stem cells.

Helen M Rowe, Adamandia Kapopoulou, Andrea Corsinotti, Liana Fasching, Todd S Macfarlan, Yara Tarabay, Stéphane Viville, Johan Jakobsson, Samuel L Pfaff, Didier Trono

Open access · bronzeAbstract read
In one paragraph

Article in Genome research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 119 papers.

0numbers the graph read from it
0cells of the map it votes in
119citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

119 citing papers in PubMed, 191 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Aberrant Expression of Human Endogenous Retroviruses andInternational journal of molecular sciences · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Multifaceted role ofMedComm · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Review

59 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 4 countries.

Helen M RoweSchool of Life Sciences and Frontiers in Genetics Program, Ecole Polytechnique Fédérale de Lausanne (EPFL), 1015 Lausanne, Switzerland.
Adamandia Kapopoulou
Andrea Corsinotti
Liana Fasching
Todd S Macfarlan
Yara Tarabay
Stéphane Viville
Johan Jakobsson
Samuel L Pfaff
Didier Trono
École Polytechnique Fédérale de Lausanne · CHInstitut de génétique et de biologie moléculaire et cellulaire · FRLund University · SESalk Institute for Biological Studies · US

Funding

Mechanisms of Mammalian Epigenome ReprogrammingZIAHD008933 · NICHD · EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT · PI MACFARLAN, TODD SCOTT · 2013 to 2025
$19.1M
Genetic Control of Motor Neuron Development and FunctionR37NS037116 · NINDS · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI PFAFF, SAMUEL L. · 2007 to 2013
$3.6M
Proto-oncogenes in Axon GuidanceR01NS054172 · NINDS · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI PFAFF, SAMUEL L. · 2007 to 2011
$2.1M
Transgenic mice and bioinformatic tools to track astrocyte diversification insituR01MH099571 · NIMH · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI MARSALA, MARTIN, PFAFF, SAMUEL L. · 2013 to 2016
$1.7M
European Research Council 268721NIMH NIH HHS R01 MH099571NINDS NIH HHS R01 NS054172NINDS NIH HHS R37 NS037116
6 · The paper itself

Abstract

TRIM28 is critical for the silencing of endogenous retroviruses (ERVs) in embryonic stem (ES) cells. Here, we reveal that an essential impact of this process is the protection of cellular gene expression in early embryos from perturbation by cis-acting activators contained within these retroelements. In TRIM28-depleted ES cells, repressive chromatin marks at ERVs are replaced by histone modifications typical of active enhancers, stimulating transcription of nearby cellular genes, notably those harboring bivalent promoters. Correspondingly, ERV-derived sequences can repress or enhance expression from an adjacent promoter in transgenic embryos depending on their TRIM28 sensitivity in ES cells. TRIM28-mediated control of ERVs is therefore crucial not just to prevent retrotransposition, but more broadly to safeguard the transcriptional dynamics of early embryos.

Indexed as

RetroelementsTranscription, GeneticAnimalsChromatinChromosome MappingDNA MethylationEmbryonic Stem CellsEndogenous RetrovirusesGene DeletionGene Expression Regulation, DevelopmentalGene SilencingGenetic LociHistonesMiceNuclear ProteinsPromoter Regions, GeneticChromatinHistonesNuclear ProteinsRepressor ProteinsRetroelementsTrim28 protein, mouseTripartite Motif-Containing Protein 28

Identifiers

PMID23233547
PMCPMC3589534
OpenAlexW2059579569

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.